Response trajectories in "real-world" naturalistically treated schizophrenia patients

Schizophrenia Research

Volumn 139, Issue 1-3, 2012, Pages 218-224

  Schennach, Rebecca ^a   Meyer, Sebastian ^a   Seemüller, Florian ^a   Jäger, Markus ^a   Schmauss, Max ^b   Laux, Gerd ^c   Pfeiffer, Herbert ^d   Naber, Dieter ^e   Schmidt, Lutz G ^f   Gaebel, Wolfgang ^g   Klosterkötter, Joachim ^h   Heuser, Isabella ⁱ   Maier, Wolfgang ^j   Lemke, Matthias R ^k   Rüther, Eckart ^l   Klingberg, Stefan ^m   Gastpar, Markus ⁿ   Musil, Richard ^a   Möller, Hans Jürgen ^a   Riedel, Michael ^a,o  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b District Hospital Augsburg   (Germany)

^c Inn Salzach Hospital Wasserburg/Inn   (Germany)

^d KLINIKUM MÜNCHEN OST   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g Department of Orthopedic Surgery   (Germany)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF BONN   (Germany)

^k Alsterdorf Hospital   (Germany)

^l UNIVERSITY OF GÖTTINGEN   (Germany)

^m UNIVERSITY OF TÜBINGEN   (Germany)

ⁿ UNIVERSITY OF DUISBURG ESSEN   (Germany)

^o Vinzenz von Paul Hospital   (Germany)

more..

Author keywords

Group membership; Heterogeneity; Response trajectory; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT; TRANQUILIZER;

ADULT; ARTICLE; DEPRESSION; DISEASE DURATION; DSM-IV; FEMALE; FUNCTIONAL STATUS; GLOBAL ASSESSMENT OF FUNCTIONING SCALE; HAMILTON SCALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATURALISTIC INQUIRY; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; REMISSION; SCHIZOPHRENIA; SOCIAL OCCUPATIONAL FUNCTIONING SCALE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL;

ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863781596     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.05.004     Document Type: Article

References (39)

1. Addington D., Addington J., Patten S. Depression in people with first-episode schizophrenia. Br. J. Psychiatry Suppl. 1998, 172:90-92.
2. Agid O., Kapur S., Arenovich T., Zipursky R.B. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch. Gen. Psychiatry 2003, 60:1228-1235.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC. Fourth edition.
4. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 2005, 162:441-449.
5. Beitinger R., Lin J., Kissling W., Leucht S. Comparative remission rates of schizophrenic patients using various remission criteria. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1643-1651.
6. Breiman L., Friedman H.J., Olshen R.A., Stone C.J. Classification and Regression Trees 1984, Wadsworth International Group, Belmont, CA.
7. Case M., Stauffer V.L., scher-Svanum H., Conley R., Kapur S., Kane J.M., Kollack-Walker S., Jacob J., Kinon B.J. The heterogeneity of antipsychotic response in the treatment of schizophrenia. Psychol. Med. 2010, 1-10.
8. Clark L.A., Pregibon D. Tree-based models. Statistical Models 1992, Wadsworth & Books/Cole Advanced Books & Software, Pacific Grove, CA. J. Chambers, T. Hastie (Eds.).
9. Cording C. Conceptual aspects in development and implementation of basic psychiatric documentation. Psychiatr. Prax. 1998, 25:175-178.
10. Correll C.U., Malhotra A.K., Kaushik S., McMeniman M., Kane J.M. Early prediction of antipsychotic response in schizophrenia. Am. J. Psychiatry 2003, 160:2063-2065.
11. Di M.V., Bolino F. The natural course of schizophrenia and psychopathological predictors of outcome. A community-based cohort study. Psychopathology 2004, 37:98-104.
12. Gaebel W. Prediction of response to acute neuroleptic treatment in schizophrenia. Int. Clin. Psychopharmacol. 1996, 11(Suppl. 2):47-54.
13. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23:56-62.
14. Haro J.M., Novick D., Suarez D., Ochoa S., Roca M. Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1287-1292.
15. Jager M., Riedel M., Messer T., Laux G., Pfeiffer H., Naber D., Schmidt L.G., Gaebel W., Huff W., Heuser I., Kuhn K.U., Lemke M.R., Ruther E., Buchkremer G., Gastpar M., Bottlender R., Strauss A., Moller H.J. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257:47-53.
16. Kay S.R., Opler L.A., Lindenmayer J.P. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res. 1988, 23:99-110.
17. Kinon B.J., Chen L., Ascher-Svanum H., Stauffer V.L., Kollack-Walker S., Zhou W., Kapur S., Kane J.M. Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology 2010, 35:581-590.
18. Leisch F. FlexMix: a general framework for finite mixture models and latent class regression in R. J. Stat. Softw. 2004, 11:1-18.
19. Leucht S., Kane J.M. Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia. J. Clin. Psychiatry 2006, 67:1813-1814.
20. Leucht S., Davis J.M., Engel R.R., Kane J.M., Wagenpfeil S. Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 2007, 32:1903-1910.
21. Levine S.Z., Leucht S. Elaboration on the early-onset hypothesis of antipsychotic drug action: treatment response trajectories. Biol. Psychiatry 2010, 68:86-92.
22. Levine S.Z., Rabinowitz J. Trajectories and antecedents of treatment response over time in early-episode psychosis. Schizophr. Bull. 2010, 36:624-632.
23. Levine S.Z., Rabinowitz J., Case M., scher-Svanum H. Treatment response trajectories and their antecedents in recent-onset psychosis: a 2-year prospective study. J. Clin. Psychopharmacol. 2010, 30:446-449.
24. Levine S.Z., Lurie I., Kohn R., Levav I. Trajectories of the course of schizophrenia: from progressive deterioration to amelioration over three decades. Schizophr. Res. 2011, 126:184-191.
25. Lieberman J., Jody D., Geisler S., Alvir J., Loebel A., Szymanski S., Woerner M., Borenstein M. Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch. Gen. Psychiatry 1993, 50:369-376.
26. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. Suppl. 1987, 334(1-100):1-100.
27. Lipkovich I.A., Deberdt W., Csernansky J.G., Buckley P., Peuskens J., Kollack-Walker S., Rotelli M., Houston J.P. Defining "good" and "poor" outcomes in patients with schizophrenia or schizoaffective disorder: a multidimensional data-driven approach. Psychiatry Res. 2009, 170:161-167.
28. Marques T.R., Arenovich T., Agid O., Sajeev G., Muthen B., Chen L., Kinon B.J., Kapur S. The different trajectories of antipsychotic response: antipsychotics versus placebo. Psychol. Med. 2010, 41(7):1481-1488.
29. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 2005, 62:975-983.
30. Muthen B., Brown C.H., Masyn K., Jo B., Khoo S.T., Yang C.C., Wang C.P., Kellam S.G., Carlin J.B., Liao J. General growth mixture modeling for randomized preventive interventions. Biostatistics 2002, 3:459-475.
31. Obermeier M., Mayr A., Schennach-Wolff R., Seemuller F., Moller H.J., Riedel M. Should the PANSS be rescaled?. Schizophr. Bull. 2010, 36(3):455-460.
32. Phillips L. Case history data and prognosis in schizophrenia. J. Nerv. Ment. Dis. 1953, 515-525.
33. R Development Core Team A Language and Environment for Statistical Computing 2008, Foundation for Statistical Computing. Ref Type: Computer Program, Vienna, Austria, URL http/:www.R-project.org.
34. Schennach-Wolff R., Jager M., Seemuller F., Obermeier M., Messer T., Laux G., Pfeiffer H., Naber D., Schmidt L.G., Gaebel W., Huff W., Heuser I., Maier W., Lemke M.R., Ruther E., Buchkremer G., Gastpar M., Moller H.J., Riedel M. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res. 2009.
35. Stauffer V., Case M., Kollack-Walker S., scher-Svanum H., Ball T., Kapur S., Kinon B.J. Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials. Schizophr. Res. 2011, 130(1-3):11-19.
36. Uher R., Muthen B., Souery D., Mors O., Jaracz J., Placentino A., Petrovic A., Zobel A., Henigsberg N., Rietschel M., Aitchison K.J., Farmer A., McGuffin P. Trajectories of change in depression severity during treatment with antidepressants. Psychol. Med. 2010, 40:1367-1377.
37. Wiersma D., Nienhuis F.J., Slooff C.J., Giel R. Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort. Schizophr. Bull. 1998, 24:75-85.
38. Wolwer W., Buchkremer G., Hafner H., Klosterkotter J., Maier W., Moller H.J., Gaebel W. German research network on schizophrenia-bridging the gap between research and care. Eur. Arch. Psychiatry Clin. Neurosci. 2003, 253:321-329.
39. Zisook S., McAdams L.A., Kuck J., Harris M.J., Bailey A., Patterson T.L., Judd L.L., Jeste D.V. Depressive symptoms in schizophrenia. Am. J. Psychiatry 1999, 156:1736-1743.